Fundraising Fox

Voyager Therapeutics, Inc.

NASDAQ: VYGR

Lexington, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

SH
Steven HymanDirector
JA
James A. GeraghtyDirector
GC
Grace ColonDirector
JO
Jude OnyiaDirector
RW
Robert W. HessleinExecutive Officer
TC
Todd CarterExecutive Officer
GP
Glenn PierceDirector
RS
Robin SwartzExecutive Officer
NV
Nancy VitaleDirector
MH
Michael HigginsDirector
AS
Alfred SandrockExecutive Officer, Director
PP
Peter PfreundschuhExecutive Officer

Investors · 2

ARCH Venture PartnersreportedChicago · $50K – $250Mvia George Scangos · board
Third Rock VenturesreportedBoston · $100K – $5Mvia Mark Levin · board

Reported raises · per SEC filings

Form D private placements
▶$20MraisedJan 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James A. GeraghtyDirector
  • Grace ColonDirector
  • Glenn PierceDirector
  • Steven HymanDirector
  • George ScangosDirector
  • Peter PfreundschuhExecutive Officer
  • Jacquelyn Fahey SandellExecutive Officer
  • Nancy VitaleDirector
  • Alfred SandrockExecutive Officer, Director
  • Michael HigginsDirector
  • Robin SwartzExecutive Officer
  • Jude OnyiaDirector
  • Catherine MackeyDirector
  • Todd CarterExecutive Officer
Offering amount
$20M
Amount sold
$20M
Sales commissions
$400K
Placement agents
Chestnut Partners, Inc.
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$39MraisedMar 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven HymanDirector
  • James A. GeraghtyDirector
  • Grace ColonDirector
  • Jude OnyiaDirector
  • Robert W. HessleinExecutive Officer
  • Todd CarterExecutive Officer
  • Glenn PierceDirector
  • Robin SwartzExecutive Officer
  • Nancy VitaleDirector
  • Michael HigginsDirector
  • Alfred SandrockExecutive Officer, Director
  • Peter PfreundschuhExecutive Officer
  • Catherine MackeyDirector
Offering amount
$39M
Amount sold
$39M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60MraisedApr 2015 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven PaulExecutive Officer, Director
  • James GeraghtyDirector
  • Mark LevinDirector
  • Mitchell S. BloomExecutive Officer
Amount sold
$60M
First sale
Apr 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.